NPH insulin
A type of insulin used to manage blood sugar levels in diabetes
NPH insulin (Neutral Protamine Hagedorn insulin) is an intermediate-acting insulin used in the management of diabetes mellitus. It is designed to help control blood sugar levels in individuals with type 1 diabetes and type 2 diabetes.
History[edit]
NPH insulin was developed in the 1940s by Hans Christian Hagedorn and B. Norman Jensen. The addition of protamine, a protein, to insulin extends its duration of action, making it suitable for basal insulin needs.
Pharmacology[edit]
NPH insulin is an intermediate-acting insulin with an onset of action of 1 to 2 hours, a peak effect occurring 4 to 12 hours after administration, and a duration of action of approximately 12 to 18 hours. It is typically administered subcutaneously.
Mechanism of Action[edit]
NPH insulin works by facilitating the uptake of glucose into cells, particularly in the liver, muscle, and fat tissue, thereby lowering blood glucose levels. The protamine component delays the absorption of insulin, providing a more prolonged effect compared to regular insulin.
Usage[edit]
NPH insulin is often used in combination with short-acting insulins to provide both basal and prandial glucose control. It is usually administered once or twice daily, depending on the individual's needs and the regimen prescribed by a healthcare provider.
Side Effects[edit]
Common side effects of NPH insulin include hypoglycemia, weight gain, and injection site reactions. Hypoglycemia is the most significant risk and requires careful monitoring of blood glucose levels.
Comparison with Other Insulins[edit]
NPH insulin is one of several types of insulin used to manage diabetes. It is less expensive than some of the newer long-acting insulins, such as insulin glargine and insulin detemir, but may require more frequent dosing and monitoring.
Administration[edit]
NPH insulin is typically administered via subcutaneous injection using a syringe, insulin pen, or insulin pump. Proper technique and rotation of injection sites are important to minimize discomfort and prevent lipodystrophy.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian